Supreme Court leaves Affordable Care Act intact, but stakeholders say healthcare reform still has a ways to go
Hospital advocates applauded a Supreme Court ruling June 17 that left the Affordable Care Act in place.
HHS sends letter to providers, insurers reinforcing requirements for COVID-19 vaccination and testing to be free for all recipients
Xavier Becerra, secretary of HHS, issued a letter emphasizing that out-of-pocket fees for COVID-19-related services are prohibited.
CMS proposes to pull support from organ acquisitions: A grave threat to the future of U.S. organ transplants and donor programs
Transplant patient lives at risk under CMS’s proposal to stop supporting donor community hospitals excising organs for non-Medicare patients on waiting lists.
Experts raise concerns about hospital merger-and-acquisition activity but differ on how Congress should respond
During a recent Senate hearing, a hospital advocate responded to criticism of consolidation stemming from mergers among hospitals and hospital acquisitions of physician practices.
Blog
Stay up-to-date with HFMA's regularly published news that covers regulatory and legislative changes and healthcare finance trends.
Congress seeks stepped-up hospital price transparency enforcement as compliance issues continue to emerge
The bipartisan leadership of a congressional committee is urging HHS to enforce price transparency rules more stringently.
HHS issues various updates to Provider Relief Fund FAQs
HHS updated its 60-page list of FAQs for recipients of Provider Relief Fund payments.
Updated FEMA guidance notes availability of monetary assistance for COVID-19 vaccination activities
The Federal Emergency Management Agency has issued updated guidance on medical care and associated costs for which monetary assistance is available during the COVID-19 public health emergency.
Unleashing the power of healthcare workforce data
Find out how one company helps healthcare organizations improve their workforce using a comprehensive assessment program to leverage real-time data and sophisticated analytics for insights on human capital and challenges.
HHS should ensure 340B hospitals remain eligible despite changes in payer mix, AHA says
Hospitals participating in the 340B Drug Pricing Program could lose access due to payer mix changes stemming from the COVID-19 pandemic unless HHS issues a waiver.